钌磺酸配合物抗体干扰导致甲状腺功能检测结果假性升高
本文报告两例患者使用Elecsys检测试剂盒出现FT4、FT3和TRAb假性升高。第一例为74岁男性被误诊为Graves病并接受甲巯咪唑治疗,第二例为48岁女性体检发现FT4和FT3升高。两例均否认服用生物素等补充剂,进一步异嗜性阻断管试验揭示血清抗体存在,且异常反应仅见于使用钌磺酸代替钌作为化学发光剂的改进试剂盒。
要点
- 钌磺酸配合物抗体可导致FT4、FT3和TRAb同时假性升高。
- 异常结果应换用其他检测方法复核,勿草率解读。
- 使用改进试剂盒仍可能出现干扰,需警惕。
核心结论
- 血清中针对钌磺酸配合物的抗体可在电化学发光免疫分析中引起FT4、FT3和TRAb假性升高,导致甲状腺功能检测结果不一致。
研究设计与样本
- 病例报告,涉及两名患者(74岁男性和48岁女性),使用Elecsys试剂盒检测,并进行异嗜性阻断管试验等进一步检查。
主要发现
- 两例患者均出现FT4、FT3和TRAb假性升高,且否认服用生物素或其他补充剂。
- 异嗜性阻断管试验揭示血清抗体存在。
- 异常反应仅在使用钌磺酸代替钌作为化学发光剂的改进试剂盒中观察到。
临床怎么用
- 遇到异常甲状腺功能检测结果时,应考虑换用其他检测方法进一步检查。
- 即使使用改进试剂盒,也不应草率解读异常结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report here two patients exhibiting a combination of falsely elevated serum levels of free thyroxine (FT4), free triiodothyronine (FT3), and thyrotropin receptor antibodies (TRAb), measured using Elecsys assay kits (Roche Diagnostics GmbH). The first patient was a 74-year-old man misdiagnosed with Graves' disease and treated with methimazole. The second patient was a 48-year-old woman whose serum FT4 and FT3 concentrations were found to be high during a blood test. These patients denied taking biotin or any other supplements. Further detailed examination, including a heterophilic blocking tube test, revealed the presence of serum antibodies. The abnormal reactions were observed only using the improved assay kits using ruthenium (Ru) sulfonate instead of Ru as a chemiluminescent agent. Therefore, serum antibodies to the Ru sulfonate complex caused the pseudo-high levels of FT4, FT3, and TRAb. To our knowledge, this is the first report showing that antibodies to the Ru sulfonate complex in the electrochemiluminescence immunoassay can cause falsely elevated levels of the combination, leading to discrepant thyroid function test results. We emphasize that in cases of abnormal test results, alternative assay methods should be considered for further examination; unusual test results should not be impulsively interpreted, even when using revised assay kits.
引用
- Takahashi S, Nishikawa M, Nishihara E, et al. Interference against a newly labeled substance with ruthenium sulfonate complexes showing discrepant thyroid function test results. Clin Chim Acta. 2023. PMID: 38101466. doi:10.1016/j.cca.2023.117706
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。